Achilles Therapeutics plc (ACHL) Misses Q3 EPS by 7c

Achilles Therapeutics plc (NASDAQ: ACHL) reported Q3 EPS of ($0.48), $0.07 worse than the analyst estimate of ($0.41).

For earnings history and earnings-related data on Achilles Therapeutics plc (ACHL) click here.

You May Also Be Interested In

• Pizza Hut CEO Aaron Powell resigns
• EU opens antidumping review of Chinese silicon metal imports
• Ai Startup Cognition Set To Raise Around $1b At A $47b Value - Bloomberg